discovery outsourcing
Taking a More Relaxed Approach to Discovery Outsourcing
February 25 by Pharma IQThe outsourcing of drug discovery functions is an increasing trend within the pharmaceutical industry. According to a recent Business Insights report entitled The Drug Discovery Outsourcing...
Case Study: Early Alliances and Risk Sharing Portfolios: An Academic’s Perspective
January 13 by Pharmaceuticals & Biotechnology EditorFrom Tactical to Strategic Partnerships: Establishing Efficient Discovery Outsourcing Strategies
November 11 by Pharma IQEffective partnerships can play a vital role in the drug discovery process and can contribute to an enhanced product pipeline and increased profitability. In this interview Richard Mo...
AstraZeneca: Discovering Drugs Through Partnerships
October 25 by Pharma IQDrug discovery projects are not cheap. The start of projects to consider new treatments for a range of diseases can be vast in their scope, meaning the development process can cost a significant amoun...
Improving Biomarker Development Work Flow in Phase I Clinical Development
September 07 by Helen WinsorReto Ossola, Group Leader for Biomarker Research at Biognosys, joins Pharma IQ to discuss the main challenges in biomarker development and some key ways to address these. Ossola offers some best...
Streamlining the Development and Validation Process in Discovery to Phase I Clinical Development
September 05 by Pharma IQReto Ossola, Group Leader for Biomarket Research at Biognosys, joins Helen Winsor from Pharma IQ, to discuss phase I clinical development. He outlines where he sees the main challenges in biomarker de...
Drug Discovery Outsourcing: Strategy, Selection & Success
April 27 by Andrea CharlesRichard Morphy from the Medicinal Chemistry Dept at the Schering-Plough Research Institute, joins Pharma IQ to discuss tactical and strategic partnerships and etablishing efficient discove...
Successfully Driving Drug Discovery and Development Using the Virtual Pharmaceutical Model
April 27 by Helen WinsorAn estimated 25 per cent of R&D budgets are now being spent on externalisation, it is crucial to develop strategic and effective business models and determine how best to outsource...
